Related by context. All words. (Click for frequent words.) 80 Castration Resistant Prostate Cancer 79 Oral Fingolimod 79 Metastatic Colorectal Cancer 79 Metastatic Prostate Cancer 78 Anti Tumor Activity 78 Relapsed Multiple Myeloma 78 Hormone Refractory Prostate Cancer 77 Neoadjuvant Chemotherapy 77 Survival Benefit 77 Adjuvant Therapy 77 Advanced Prostate Cancer 77 Improves Survival 77 Adjuvant Chemotherapy 77 Antitumor Activity 77 Pooled Analysis 77 Renal Cell Carcinoma 77 Newly Diagnosed Multiple Myeloma 76 Rheumatoid Arthritis Patients 76 Prolongs Survival 76 Critically Ill Patients 76 Clinical Outcome 76 Improves Outcomes 76 Adjuvant Treatment 76 Autologous Stem Cell Transplantation 76 Myeloma Patients 76 Soft Tissue Sarcoma 76 Localized Prostate Cancer 76 Study Evaluating 76 Carotid Stenting 75 Myelodysplastic Syndromes 75 Advanced Melanoma 75 Radical Prostatectomy 75 Elderly Patients 75 Follicular Lymphoma 75 Patients Undergoing 75 Phase 2b Clinical Trial 75 Relapsing Remitting Multiple Sclerosis 75 Bone Metastases 75 Well Tolerated 75 Novel Oral 75 Unresectable 75 Statistically Significant 75 Pharmacokinetic Study 75 Previously Untreated 75 HER2 Positive Breast Cancer 75 Phase IIb Clinical Trial 75 Cutaneous T 75 Clinical Trial Results 75 Improve Survival 75 Chronic Hepatitis C 74 Meets Primary Endpoint 74 Hormone Receptor Positive 74 Patients Treated With 74 Relapsing Multiple Sclerosis 74 Colorectal Cancer Patients 74 Treated Patients 74 Monotherapy 74 Total Knee Arthroplasty 74 Statin Therapy 74 Advanced Renal Cell 74 Ovarian Cancer Patients 74 Unfractionated Heparin 74 Prostate Cancer Patients 74 Patients Treated 74 Improved Survival 74 Brain Metastases 74 Lung Cancer Trial 74 Previously Treated 73 Prostate Biopsy 73 Advanced Ovarian Cancer 73 Chemotherapy Improves 73 Appears Safe 73 Patients Suffering 73 Subgroup Analysis 73 Is Well Tolerated 73 Liver Metastases 73 Phase 2a Clinical Trial 73 Diabetic Patients 73 Knee Osteoarthritis 73 Advanced Colorectal Cancer 73 Disease Progression 73 Gastrointestinal Stromal Tumors 73 Relapsed Refractory 73 Randomized Trials 73 Preclinical Data 73 Anticancer Activity 73 Inhaled Corticosteroids 73 Complicated Skin 73 II Clinical Trial 73 Phase 2b Trial 73 Dose Escalation 73 Androgen Deprivation Therapy 73 Treatment Experienced 73 Phase IIb Trial 73 Study Showed 73 Demonstrates Positive 73 Bare Metal Stents 73 Hematological Cancers 73 Lung Cancer Patients 73 Ischemic Stroke 73 Solid Tumors 73 Shows Promising 73 Chemoradiation 73 Investigational Agent 73 Randomized Phase 72 Less Invasive 72 Metastatic Pancreatic Cancer 72 Left Ventricular Hypertrophy 72 Pivotal Phase 72 Breast Cancer Recurrence 72 Phase III Clinical Trial 72 Combination Treatment 72 Phase 2b Study 72 Novel Inhibitor 72 Demonstrated Significant 72 Resistant Hypertension 72 Physical Function 72 Drug Candidate 72 Long Term Outcomes 72 Gastric Cancer 72 Tumor Growth 72 Glufosfamide 72 Severe Sepsis 72 Peginterferon Alfa 2a 72 Plaque Psoriasis 72 ST Elevation Myocardial 72 Gene Mutation 72 Antiviral Activity 72 Nicotine Vaccine 72 Intracranial Aneurysms 72 Kidney Function 72 Multiple Myeloma Patients 72 Liver Tumors 72 Gene Variation 72 Gene Variant 72 Demonstrate Significant 72 Randomized Double Blind 72 Prophylactic Treatment 72 Treatment Regimen 72 Renal Function 72 Treatment Naive Patients 72 Randomized Phase II 72 Cardiac Resynchronization 72 Sirolimus Eluting Stent 72 Newly Diagnosed Breast Cancer 72 Randomized Clinical Trials 72 Radiofrequency Ablation 72 Phospholipase A2 72 Phase III Trial 71 Randomized Clinical Trial 71 Phase 2a Trial 71 Phase 1b Clinical Trial 71 Advanced Solid Tumors 71 Long Term Survival 71 Carboplatin Paclitaxel 71 Patients Receiving 71 Kidney Transplant Patients 71 Novel Antibiotic 71 Immune Responses 71 Newly Diagnosed 71 Lung Cancer Survival 71 Randomized Phase III 71 Sleep Disturbances 71 Diabetic Neuropathic Pain 71 Pre Cancerous 71 Aggressive Prostate Cancer 71 See CLINICAL PHARMACOLOGY 71 Secondary Hyperparathyroidism 71 Anti Tumor 71 Stent Restenosis 71 Dose Ranging 71 Breast Cancers 71 Fewer Side Effects 71 Postmenopausal Osteoporosis 71 Treatment Naïve 71 Trial Evaluating 71 Fungal Infections 71 Cardiovascular Events 71 Plus Ribavirin 71 Mouse Model 71 Desvenlafaxine Succinate 71 Genes Predict 71 Endothelial Cells 71 Placebo Controlled Trial 71 Chronic Myeloid Leukemia 71 Combination REOLYSIN R 71 Lung Cancers 71 Investigational Drug 71 Obese Patients 71 Acute Ischemic Stroke 71 Dendritic Cells 71 Lymph Node 71 Heart Failure Patients 71 Induction Therapy 71 Significantly Reduced 71 Patient Enrollment 71 Antiplatelet Therapy 71 Osteoporosis Drugs 71 Long Term Efficacy 71 Nymox NX 71 Refractory Hodgkin Lymphoma 71 Complete Remission 71 Hemodialysis Patients 71 Left Ventricular 71 Confirmatory Phase 71 Chemotherapy Regimen 71 Advanced Pancreatic Cancer 71 Prostate Tumors 71 Tumor Response 71 Pivotal Study 71 Spinal Fractures 71 Clinical Trial Evaluating 71 Treatment Reduces 71 Minimally Invasive Treatment 71 Watchful Waiting 71 Versus Placebo 71 Hepatitis C Infection 71 Septic Shock 71 Prognostic Value 71 Multicenter Trial 71 Inhaled Nitric Oxide 71 Depressive Symptoms 70 Pediatric Patients 70 Treating Chronic 70 Proves Effective 70 Infected Patients 70 Predict Risk 70 Skeletal Muscle 70 Topline Results 70 Drug Prevents 70 Randomized Controlled Trials 70 Laryngeal Cancer 70 Metastatic 70 Diffuse Large B 70 Shows Promise Against 70 Recurrent Breast Cancer 70 Hypertensive Patients 70 Chronic Hepatitis B 70 Drug Shows Promise 70 Postmenopausal Women 70 Cyclophosphamide 70 HER2 Positive 70 Signaling Pathways 70 Combo Therapy 70 Acute Myocardial Infarction 70 Malignant Glioma 70 Vertebral Fractures 70 Adjunctive Therapy 70 Chronic Sinusitis 70 Pivotal Phase III 70 Recurrent Ovarian Cancer 70 Rectal Cancer 70 Stent Implantation 70 Sirolimus Eluting 70 Cardiotoxicity 70 Unstable Angina Non 70 Combination Clinical Trial 70 Renal Cancer 70 Endovascular Treatment 70 Breast Tumors 70 Pharmacyclics Announces 70 Genetic Defect 70 Bone Marrow Cells 70 Cell Lymphoma 70 Overactive Bladder 70 Diabetic Nephropathy 70 Carotid Endarterectomy 70 Fracture Risk 70 Pulmonary Arterial Hypertension 70 Stem Cell Transplants 70 Lupus Drug 70 Antigen Specific 70 Lung Tumors 70 Stent Thrombosis 70 Colorectal Adenomas 70 Neoadjuvant 70 Tyrosine Kinase Inhibitor 70 Metastatic Disease 70 Gout Drug 70 Panic Disorder 70 Dose Ranging Study 70 Significant Reduction 70 Myelofibrosis 70 Contrast Agents 70 Meta Analysis 70 Immune Cell 70 Radiation Dose 70 Peripheral Blood 70 Benign Prostatic Hyperplasia 70 Partial Onset Seizures 70 Estrogen Therapy 70 Investigational Treatment 70 Circulating Tumor Cells 70 Renal Cell Cancer 70 Catheter Ablation 70 Relapsed Refractory Aggressive 70 Breast Density 70 Treatment Shows Promise 70 Metastatic Melanoma 70 Phase Ib Clinical Trial 70 Kidney Transplants 70 Cognitive Impairment 70 Non Responders 70 Single Dose 70 Increased Mortality 70 Targeted Therapy 69 Immunomedics Announces 69 Non Inferiority 69 Trastuzumab 69 Prospective Randomized 69 Viral Suppression 69 Cardiovascular Disease Risk 69 Gastric Ulcers 69 Patient Outcomes 69 Autoimmune Disorders 69 Anti Inflammatory Drug 69 Progenitor Cells 69 Preclinical Study 69 Induction Chemotherapy 69 Drug Combo 69 Kinase Inhibitor 69 Placebo Controlled Study 69 J Shoulder Elbow 69 Urinary Incontinence 69 Randomized Study 69 Severe Asthma 69 Hip Fractures 69 Slow Progression 69 Diabetic Kidney Disease 69 Anticancer Drugs 69 Bevacizumab 69 Kidney Tumors 69 Bortezomib 69 Cervical Dysplasia 69 Anthracycline 69 Prognostic Factors 69 Peginterferon 69 Atypical Hemolytic Uremic Syndrome 69 Artery Disease 69 Aurora Kinase 69 Malignancies 69 ST Segment Elevation 69 Pivotal Trial 69 ORLive Presents 69 Renal Tumors 69 Significantly Improved 69 Acute Coronary Syndromes 69 Leukemias 69 Fludarabine 69 Hepatitis C Genotype 69 Reduces Pain 69 Lowering Blood Pressure 69 Malignant Melanoma 69 Cardiac Function 69 Prostate Cancer Recurrence 69 Antidepressants Linked 69 Node Positive 69 JAK Inhibitor 69 Gene Linked 69 Hsp# Inhibitor 69 Shows Efficacy 69 Platinol ® 69 Renal Impairment 69 Hedgehog Pathway 69 Breast Cancer Patients 69 Synta Announces 69 Treatment Naive HIV 69 Multicenter Phase 69 Dose Finding 69 Lowers Risk 69 Clinical Efficacy 69 Glycemic Control 69 Enzo Biochem Reports 69 Demonstrates Significant 69 Decitabine 69 Sustained Reduction 69 Sangamo BioSciences Announces 69 Electrical Stimulation 69 Phase III Trials 69 Mouse Models 69 Squamous Cell Carcinoma 69 Liver Failure 69 Chronic Renal Failure 69 Seasonal Allergic Rhinitis 69 Spectrum Pharmaceuticals Announces 69 Post Operative 69 Chronic Lymphocytic Leukemia 69 Cardiovascular Outcomes 69 achieved CCyR 69 Venous Thromboembolism 69 Premenopausal Women 69 Endothelial Function 69 Myocardial Ischemia 69 Antibiotic Treatment 69 Cognitive Problems 69 Prognostic Significance 69 Systolic Blood Pressure 69 Cell Transplants 69 Interferon Beta 69 IND Filing 69 Gene Variants 69 Naive Patients 69 Double Blind Placebo 69 Ischemic 69 Bipolar Depression 69 Radioimmunotherapy 69 Preclinical Models 69 Initiate Phase III 69 CCX# B 69 Clostridium difficile Infection 69 HCV Protease Inhibitor 69 Genetic Variant 69 Hepatocellular Carcinoma 69 Genetic Mutations 69 Adenoma 69 Blood Pressure Drug 69 Lung Cancer Drug 69 Combination Therapy 68 Orally Active 68 Lipid Levels 68 Corneal Transplant 68 Tolerability 68 Randomized Double blind 68 Minimally Invasive Procedure 68 Surgical Procedures 68 Paclitaxel Carboplatin 68 Androgen Deprivation 68 Clinical Trial Data 68 Radiation Induced 68 Breast Cancer Stem Cells 68 Bipolar Mania 68 Osteoporosis Drug 68 Completes Patient Enrollment 68 Diabetic Foot Ulcer 68 Genetic Mutation 68 Patients Enrolled 68 Sipuleucel T 68 Osteoarthritis Patients 68 Antitumor 68 Treatment Naive 68 FDA Approves Drug 68 Kinase Inhibitors 68 Coronary Angiography 68 Enlarged Prostate 68 AnaSpec Introduces 68 Prostate Cancer Treatment 68 Genes Linked 68 Controlled Study 68 Treatment Resistant 68 NDA Submission 68 Treat Heart Failure 68 Cancer Recurrence 68 Often Misdiagnosed 68 Lymph Nodes 68 Inhibits 68 Insulin Glargine 68 Recombinant Human 68 Significantly Reduces 68 Potentially Fatal 68 Boosts Survival 68 Demonstrates Efficacy 68 HDAC Inhibitor 68 Statistically Significant Improvement 68 Epidermal Growth Factor Receptor 68 Epratuzumab 68 Controlled Trial 68 Completes Enrollment 68 Effectively Treats 68 Prostatectomy 68 Lupus Nephritis 68 Therapy Improves 68 Randomized Double Blind Placebo 68 Medullary Thyroid Cancer 68 Phase IIa Clinical Trial 68 Organ Rejection 68 Nilotinib 68 Ranolazine 68 Limb Ischemia 68 Statin Use 68 Abiraterone Acetate 68 Levels Linked 68 Thrombotic 68 Bladder Cancer 68 Epithelial Cell 68 Carcinomas 68 EntreMed Presents 68 Infarct 68 Tumor Cells 68 Balloon Angioplasty 68 Anticancer Drug 68 Pegylated Liposomal Doxorubicin 68 Genetic Variants 68 Robotic Assisted 68 Experimental Vaccine 68 Blocked Arteries 68 Viral Load 68 Cerebrospinal Fluid 68 Arch Facial Plast 68 Protein Linked 68 Therapeutic Efficacy 68 Smooth Muscle 68 Migraine Headaches 68 Study Shows Promise 68 Anti Clotting Drug 68 Low Dose 68 Brain Atrophy 68 Sustained Efficacy 68 Angiographic 68 Chronic HCV 68 Demonstrates Sustained 68 Initiate Phase 68 Pulmonary Artery 68 Male Contraceptive 68 Secondary Endpoints 68 Regenerative Cells 68 Serious Infections 68 Prostate Cancers 68 Cholesterol Lowering Drug 68 Tumor Cell 68 ACE Inhibitors 68 Skin Lesions 68 Blood Pressure Lowering 68 Valve Replacement 68 Fulvestrant 68 NPS Pharmaceuticals Announces 68 Asthma Treatment 68 Study Demonstrates 68 Receives Orphan Drug Designation 68 familial amyloidotic polyneuropathy FAP 68 Metastases 68 Commonly Used 68 Capsules CII 68 Teva Provides Update 68 Hypercholesterolemia 68 Aortic Stenosis 68 Drug Resistant 68 Natalizumab 68 Predict Prostate Cancer 68 Zoledronic Acid 68 Percutaneous Tibial Nerve Stimulation 68 Cognitive Decline 68 SPRYCEL ® 68 Improve Outcomes 68 Newly Diagnosed Patients 68 Tumor Progression 68 Stent Placement 68 Predict Breast Cancer 68 CYT# potent vascular disrupting 68 Node Negative 68 Allogeneic 68 Chronic Pelvic Pain 68 Investigational Compound 68 Data Suggest 68 Lung Cancer Diagnosis 68 Slows Progression 68 Chronic Myelogenous Leukemia 68 Muscle Wasting 67 Treating Depression 67 Novel Method 67 Survival Rates 67 Preterm Delivery 67 Protease Inhibitor 67 Lung Function 67 Hepatitis C Patients 67 Hepatocellular 67 Ventricular Arrhythmias 67 External Beam 67 First Patient Enrolled 67 Clinically Significant 67 Certain Cancers 67 Showed Significant 67 Partial Nephrectomy 67 Breast Tissue 67 Inflammatory Arthritis 67 Bloodstream Infections 67 Chronic Constipation 67 First Patient Treated 67 Polymerase Inhibitor 67 Osteoporosis Treatment 67 Brentuximab Vedotin SGN 67 Anthrax Toxin 67 Novel Compound 67 Bosutinib 67 Pivotal Clinical Trial 67 Hepatitis C Treatment 67 Adjuvant Breast Cancer 67 Thyroid Hormone 67 Chronic Heart Failure 67 Prostate Cancer Survival 67 Interferon Gamma 67 Significant Improvement 67 Demonstrates Potent 67 Cholesterol Levels 67 Peginterferon Alfa 2b 67 Cardiogenic Shock 67 Tiotropium 67 Prostate Cancer Progression 67 Coronary Artery 67 Metastatic Breast Cancer 67 B Cell Malignancies 67 Drug Coated Stents 67 Venous Thrombosis 67 Recurrent Glioblastoma 67 Dasatinib 67 Lipid Lowering 67 Proc Am Soc 67 Perifosine KRX 67 Telik Announces 67 Blood Clot Risk 67 Inflammatory Pain 67 AVI BioPharma Announces 67 Diabetic Foot Ulcers 67 Systemic Sclerosis 67 Novel Mechanism 67 Transplant Patients 67 Leukemia Cells 67 Pharmacokinetics PK 67 Capecitabine 67 Genes Involved 67 Cancer Treatments 67 Migraine Drug 67 Activator CK # 67 Treatment Naïve Patients 67 Hernia Repair 67 J Clin 67 Coronary Artery Bypass Surgery 67 Intracerebral Hemorrhage 67 JAK2 Inhibitor 67 FDA Approvals 67 Atypical Antipsychotics 67 Blood Pressure Drugs 67 Antipsychotic Drugs 67 Survival Rate 67 Relapsed 67 Stomach Cancer 67 Valvular Heart Disease 67 Tumor Suppressor 67 Breast Cancer Treatment 67 Ovarian Cancers 67 undergoing Percutaneous Coronary 67 Menstrual Pain 67 Renal Artery 67 Cholinesterase Inhibitors 67 Therapy Reduces 67 Helps Predict 67 Brain Stimulation 67 Epilepsy Drug 67 Colorectal Cancers 67 Renal Anemia 67 Contrast Agent 67 Drug Eluting 67 Breast Cancer Cells 67 Spinal Fusion 67 Efficacy Trial 67 Ovarian Cancer Risk 67 Endometrial Cancer 67 Phase III Pivotal 67 RNAi Therapeutic 67 Tezampanel 67 Invasive Breast Cancer 67 Virus Linked 67 Epilepsy Drugs 67 Sandostatin R 67 Retreatment 67 Reduce Mortality 67 Bone Mineral Density 67 First Patient Dosed 67 TO AVOID PREGNANCY WHILE 67 Moderate Drinking 67 Inflammatory Markers 67 Clot Risk 67 Pegylated Interferon 67 Blood Cancers 67 Blood Flow 67 Fibromyalgia Pain 67 Signaling Pathway 67 Mimetics 67 Statistical Significance 67 Paraplatin ® 67 J Foot Ankle 67 Relapsed Refractory Multiple Myeloma 67 Metastatic Cancer 67 Emerging Therapies 67 Gentium Announces 67 CT Angiography 67 J Cataract Refract 67 Chronic Cough 67 Functional Outcomes 67 Bivalirudin 67 Xenografts 67 Colorectal Cancer Risk 67 Romidepsin 67 Breast Carcinoma 67 Lenalidomide 67 Cancer Cells 67 Chronic Stress 67 Presents Preclinical Data 67 follicular lymphomas 67 Hormonal Therapy 67 Genetic Tests 67 Randomized Placebo Controlled Trial 67 Vertebral Compression Fractures 67 Stereotactic Body Radiation Therapy 67 sunitinib Sutent ® 67 Allergic Reactions 67 Bone Fractures 67 Renal Insufficiency 67 Chronic Lymphocytic Leukemia CLL 67 Humanized Anti 67 Subtypes 67 Stent Coating 67 Interferon Alfa 67 Advanced Gastric Cancer 67 Angiogenic 67 Monoclonal Antibody 67 Free Survival PFS 67 Opioid Use 67 Mitral Regurgitation 67 Thrombolysis 67 Placebo Controlled 67 Late Breaker 67 REMINDER ORLive Presents 66 Disease Modifying 66 Orthostatic Hypotension 66 Remission Maintenance 66 Acute Heart Failure 66 Hemolysis 66 Beneficial Effects 66 dasatinib Sprycel ® 66 CIMZIA ™ 66 Erectile Dysfunction Drug 66 Ovary Removal 66 Crowflight Announces 66 Clin Oncol 66 Hospitalized Patients 66 Enzyme Replacement Therapy 66 Bone Marrow Transplants 66 Hematological Malignancies 66 unfractionated heparin UFH 66 Eculizumab 66 Prolongs Life 66 Asthma Symptoms 66 Nuvelo Announces 66 Pivotal Phase II 66 Chemotherapeutic Agents 66 Hematopoietic Stem Cells 66 Shown Effective 66 Randomized Controlled 66 Erosive 66 Infarction 66 FDA Okays 66 Left Ventricular Dysfunction 66 Cytotoxicity 66 Technological Advances 66 Acute Pancreatitis 66 complement inhibitor eculizumab 66 Inherited Diseases 66 Progressive Multifocal Leukoencephalopathy 66 Obesity Linked 66 R Bortezomib 66 Foot Ankle 66 Sustained Virologic Response 66 Efficacious 66 Systemic Delivery 66 Brain Scans 66 Antipsychotic Drug 66 Corticosteroid 66 Cyclooxygenase 2 66 Cognitive Function 66 Pivotal Trials 66 Stem Cell Procedure 66 Ibritumomab Tiuxetan 66 Investigational Oral 66 Protein Synthesis 66 Beta Blockers 66 Disease Severity 66 Contrast Enhanced 66 Epoetin Alfa 66 Prostate Cancer Vaccine 66 Breast Ultrasound 66 Phase IIa Trial 66 Kidney Transplant Recipients 66 stage IIIB 66 Stem Cell Treatment 66 Left Atrial 66 Active Rheumatoid Arthritis 66 Antitumor activity 66 Liver Toxicity 66 Rheumatoid Arthritis Drug 66 PEGylated Fab fragment 66 Paclitaxel Eluting 66 Differential Diagnosis 66 Oral Cladribine 66 Brain Aneurysms 66 Oral Calcitonin 66 Bare Metal Stent 66 Dose Response 66 Collaborators Present 66 Migraine Relief 66 8mg/kg 66 Primary Endpoint 66 Juvenile Idiopathic Arthritis 66 Malignant Pleural Mesothelioma 66 Endovascular Repair 66 Test Detects 66 Histone Deacetylase 66 Insulin Sensitivity 66 Treat Anemia 66 Vildagliptin 66 CYP#A# CYP#D# 66 Prospective Randomized Study 66 ISTODAX ® 66 Highly Accurate 66 Neovascular Age Related Macular 66 Treating Heart Failure 66 Therapy Shows Promise 66 Hematological 66 Insulin Resistance 66 Gene Mutations 66 Inflammatory Diseases 66 Schiavo Autopsy 66 Randomised Trial 66 Stenting 66 R# #mg BID 66 Fondaparinux 66 Immunosuppression 66 Synthetic Peptide 66 Present Preclinical Data 66 Psychiatric Disorders 66 Blood Vessels 66 Abdominal Fat 66 Virus Infection 66 Medoxomil 66 Aspirin Reduces 66 Arterial Disease 66 Gemcitabine 66 Factor Receptor 66 Portal Hypertension 66 Allergic Rhinitis 66 Severe Acne 66 Cancer Therapies 66 Menopausal Women 66 Respiratory Distress 66 Multicenter Study 66 Neuroendocrine Tumors 66 Schizophrenia Treatment 66 Dual Antiplatelet Therapy 66 Initiates Clinical Trial 66 metastatic malignant 66 Cholesterol Drugs 66 Dementia Risk 66 Therapeutic Potential 66 Brain Tumor Patients 66 Osteoarthritis Knee Pain 66 Reduces Mortality 66 Tumor Necrosis Factor 66 Statin Drugs 66 Vaccine Candidate 66 Symptom Improvement 66 Carcinoma 66 Aortic Valve 66 Xelox 66 Myelodysplastic Syndrome 66 Solid Malignancies 66 Study Shows Benefits 66 Rotavirus Vaccine 66 Modulates 66 Aflibercept 66 Surgical Treatment 66 Recurrent Prostate Cancer 66 Sleep Duration 66 Liver Injury 66 Multicenter Randomized 66 Viral Infections 66 Telaprevir VX 66 Restenosis 66 Image Guided 66 Cell Adhesion 66 Phase III Clinical Trials 66 Genetic Markers 66 Pharmacodynamics 66 Blood Clots 66 Diabetic Neuropathy 66 moderate renal impairment 66 Surgery Performed 66 Platelet Inhibition 66 Childhood Trauma 66 Mayo Clinic Study Finds 66 Unstable Angina 66 Hormone Therapy 66 Relieves Pain 66 Cilostazol 66 Lymphocytic 66 Pulmonary Vein Isolation 66 Poster Presentations 66 Skin Cells 65 Imaging Techniques 65 Iron Overload 65 icatibant 65 Epithelial 65 PEGylated interferon beta 1a 65 Nat Clin Pract 65 Successfully Completes Phase 65 Multicenter Randomized Double 65 Findings Reveal 65 Magnetic Nanoparticles 65 Acute Migraine 65 Study Shows Significant 65 Coronary Artery Bypass Graft 65 Vitro Activity 65 Patient Treated 65 Testosterone Levels 65 fosbretabulin 65 Refractory Angina 65 Genes Identified 65 Premature Infants 65 Percutaneous Coronary Intervention 65 Hepatic Encephalopathy 65 Uterine Fibroid Embolization 65 Significantly Improves 65 Vertebroplasty 65 Adverse Outcomes 65 Novel Therapeutic 65 Granted Orphan Drug 65 Heart Transplant Recipients 65 Chemotherapy Induced 65 Biologic Therapy 65 Newly Diagnosed Chronic Myeloid 65 Sex Hormones 65 Transplant Rejection 65 intravesical infusion therapy 65 Confirms Efficacy 65 Non Invasive Treatment 65 Dose Reduction 65 Inflammatory Disease 65 Uric Acid 65 Gastrointestinal Disorders 65 bone marrow reticulin deposition 65 Fluorouracil 65 Novel Compounds 65 Lowers Blood Pressure 65 Attenuates 65 FOLFOX6 chemotherapy regimen 65 Comorbidities 65 Skin Grafts 65 Vasomotor Symptoms 65 myelodysplastic myeloproliferative diseases 65 Gum Disease 65 Files IND 65 Meet Primary Endpoint 65 Abciximab 65 Obese Teens 65 Genes Associated 65 Imaging Technique 65 Nephrectomy 65 ACTEMRA TM 65 Reduces Risk 65 Diagnostic Tools 65 NMDA Receptor 65 Antiviral Therapy 65 Sentinel Lymph Node Biopsy 65 FOLFOX6 65 RNAi Therapeutics 65 Hemoglobin Levels 65 Blood Pressure Reduction 65 Eluting Stent 65 Exercise Reduces 65 Demonstrates Potential 65 Chronic Liver Disease 65 Cytotoxic 65 Induces 65 Breast Tumor 65 Taxane 65 Brain Lesions 65 Potent Antiviral Activity 65 Therapeutic Targets 65 Oral Mucositis 65 Phospholipase 65 Invasive Fungal Infections 65 Randomized Controlled Trial 65 Poniard Pharmaceuticals Announces 65 Generalized Anxiety Disorder 65 Patient Accrual 65 Skin Cancers 65 Receptor Agonist 65 Nucleoside 65 Hyperlipidemia 65 Clinically Tested 65 Childhood Leukemia 65 Hepatitis C Virus Infection 65 Enoxaparin 65 Stromal Cells 65 Lymphoid 65 Severe Psoriasis 65 PROSTASCINT R 65 Medicure Announces 65 bortezomib refractory 65 Voreloxin 65 Painkiller Abuse